when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

the cabinet

Drugs

6,918 products tracked

★ save view ↓export CSV

phase

all Marketed Phase 3 Phase 2 Phase 1 Preclinical

sort

catalysts recent name

therapeutic area

all Oncology1831 Infectious Disease718 Cardiology425 Pulmonology396 Immunology371 Ophthalmology368 Dermatology300 Women's Health131

Phase 2
naronapride
naronapride
Diabetic Gastroparesis Renexxion LLC
Marketed
natalizumab
Tysabri (natalizumab)
Crohn's Disease (Regional Enteritis)$BIIB BIOGEN INC.
Marketed
natamycin
Natacyn (natamycin)
Blepharitis$HROW HARROW, INC.
Marketed

page 198 of 231

Type 2 Diabetes

Modavar Pharmaceuticals LLC

Phase 3

navacaprant hydrochloride

navacaprant hydrochloride

Major Depressive Disorder$NMRA Neumora Therapeutics, Inc.

Phase 3

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…$BCRX BIOCRYST PHARMACEUTICALS INC

Phase 2

Fallopian Tube Cancer Feng Biosciences Inc

Phase 3

navitoclax dihydrochloride

navitoclax dihydrochloride

Myelofibrosis$ABBV AbbVie Inc.

Phase 2

Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis) Kartos Therapeutics Inc

Phase 2

Danyelza (naxitamab-gqgk)

Neuroblastoma Y-mAbs Therapeutics Inc

Phase 3

Refractory Acute Myeloid Leukemia$MBRX Moleculin Biotech, Inc.

Marketed

nebivolol hydrochloride

Nebivolol Hydrochloride

Hypertension Beximco Pharmaceuticals USA Inc

Phase 2

Primary Sclerosing Cholangitis$CMMB Chemomab Therapeutics Ltd.

Marketed

Portrazza (necitumumab)

Squamous Non-Small Cell Lung Cancer Eli Lilly and Co

Preclinical

nedaplatin [INN]

Esophageal Cancer RNR BioMedical Inc

Phase 2

Neurofibromatoses Type I (Von Recklinghausen's Disease) NFlection Therapeutics Inc

Marketed

nedosiran sodium

Rivfloza (nedosiran sodium)

Primary Hyperoxaluria Type II Novo Nordisk AS

Marketed

nefazodone hydrochloride

Nefazodone Hydrochloride

Major Depressive Disorder Teva Pharmaceuticals USA Inc

Phase 2

Frontotemporal Dementia (Pick Disease)$CRVO CervoMed Inc.

pre_registration

Non-Small Cell Lung Cancer$NUVL Nuvalent, Inc.

Phase 1

Chronic Lymphocytic Leukemia (CLL)$MRKR Marker Therapeutics, Inc.

Marketed

nelfinavir mesylate

Viracept (nelfinavir mesylate)

Human Immunodeficiency Virus (HIV) Infections (AIDS)$PFE PFIZER INC

Phase 2

Nemluvio (nemolizumab)

Systemic Sclerosis (Scleroderma) Galderma SA

Phase 2

Taigexyn (nemonoxacin [INN])

Diabetic Foot Infection (DFI) TaiGen Biotechnology Co Ltd

Phase 2

Follicular Lymphoma$MRK Merck & Co., Inc.

Marketed

neomycin sulfate

Neomycin Sulfate

Hepatic Encephalopathy X-GEN Pharmaceuticals DJB Inc

Marketed

Ilevro (nepafenac)

Ocular Inflammation$HROW HARROW, INC.

Phase 1

nepicastat hydrochloride

nepicastat hydrochloride

Ulcerative Colitis Asieris Pharmaceuticals (USA) Inc

Marketed

Nerlynx (neratinib)

Metastatic Brain Tumor$PBYI PUMA BIOTECHNOLOGY, INC.

Phase 3

neridronic acid

neridronic acid [INN]

Complex Regional Pain Syndrome (Sympathetic Reflex Dystro… Ambros Therapeutics Inc